Skip to main navigation
Skip to search
Skip to main content
Sort by
Biochemistry, Genetics and Molecular Biology
Synuclein
100%
Stem Cell
92%
Induced Pluripotent Stem Cell
64%
MicroRNA
58%
Alpha-Synuclein
42%
Maturity Onset Diabetes of the Young
40%
Cancer Cell
35%
Signal Transduction
35%
Long Non-Coding RNA
34%
Intellectual Disability
33%
Blood Plasma
31%
Long Noncoding RNA
29%
Transcriptome
29%
Transcriptomics
29%
Gene Expression
29%
Messenger RNA
29%
Insulin
28%
T Cell
28%
Stem Cell Line
28%
Human Induced Pluripotent Stem Cell
27%
DNA Methylation
27%
Transcription Factors
27%
Gene Expression Profiling
25%
Candidate Gene
25%
Carcinogenesis
24%
Molecular Mechanism
22%
Promoter Region
22%
Genetic Divergence
21%
Deficiency
21%
SARS Coronavirus
21%
Glucose
20%
Missense
19%
Non-Coding RNA
19%
Cell Proliferation
18%
Upregulation
18%
Immune Checkpoints
18%
Prevalence
18%
Polygenic Score
18%
Genome-Wide Association Study
18%
PDX1
18%
Reprogramming
18%
Gene Signature
18%
Cell Migration
18%
Insulin Resistance
17%
RNA Sequencing
17%
Small Interfering RNA
17%
Cell Maturation
16%
Bioinformatics
15%
Downregulation
15%
Cell Cycle
15%
Regulatory Network
15%
Quantitative Reverse Transcription Polymerase Chain Reaction
15%
Tau
14%
CRISPR/Cas9
14%
Methylation
14%
FOXA2
14%
Genetic Risk
14%
Doxorubicin
14%
CRISPR
14%
Lactate Dehydrogenase
13%
Zebra Fish
13%
RNA
13%
Genome Wide Association Study
13%
Exome Sequencing
13%
Cellular Differentiation
13%
Stromal Cell
13%
Enzyme
12%
PD-L1
12%
DNA Damage Response
12%
Immunocompetent Cell
12%
Immune Response
12%
Autosomal Recessive Inheritance
11%
Comorbidity
11%
Amyloid Protein
11%
Mouse Model
11%
Cell Membrane
11%
Cell Survival
11%
Amino Acid
11%
Embryonic Stem Cell
11%
Oxidative Stress
11%
Adipocyte
11%
CD4
11%
Osteoblast
11%
Peptide
11%
Cancer Model
10%
Wild Type
10%
Embryogenesis
10%
Proband
10%
Monoclonal Antibody
10%
Colony Formation
10%
Histone
10%
phosphorylation
10%
Insulin Release
10%
Genetic Architecture
10%
Prognostic Biomarker
10%
Epigenetic Regulation
9%
Inheritance
9%
Autosomal Dominant Inheritance
9%
Body Mass
9%
Tumor Necrosis Factor
9%
Keyphrases
Alpha-synuclein (α-syn)
80%
Parkinson's Disease
56%
Induced Pluripotent Stem Cells (iPSCs)
40%
Human Pluripotent Stem Cells (hPSCs)
34%
Breast Cancer
32%
Long Non-coding RNA (LncRNA)
25%
Triple-negative Breast Cancer
25%
MicroRNA
24%
Qatar
24%
Alzheimer's Disease
21%
Alzheime's Disease
21%
Pancreatic Progenitors
18%
Diabetes
18%
Type 2 Diabetes Mellitus (T2DM)
17%
Pancreatic Cells
17%
Neurodegeneration
16%
Synucleinopathy
16%
Pluripotent Stem Cell Line
15%
Fibril Formation
14%
Obesity
14%
Colorectal Cancer
14%
Genome-wide Association Study
14%
Stem Cell-derived
14%
Cerebrospinal Fluid
13%
Lewy Bodies
13%
Meta-analysis
13%
Potential Biomarkers
12%
Phosphorylated α-synuclein
12%
Tumor
12%
Genetic Risk
12%
Pre-diabetes (pre-DM)
12%
NKX6.1
11%
Transcription Factor
11%
DNA Methylation (DNAm)
11%
In Cancer
11%
MicroRNA Profiling
11%
Kallmann Syndrome
11%
Prognostic Biomarker
11%
COVID-19
11%
HepG2 Cells
11%
Exendin-4
11%
SRY-box Transcription Factor 9 (SOX9)
11%
PDX1
11%
Macrophages
10%
Breast Cancer Patients
10%
Steatosis
10%
Gene Signature
10%
Small Interfering RNA (siRNA)
10%
B Cells
9%
Polygenic Risk Score
9%
Autism Diagnosis
9%
Glucagon-like
9%
Normal Weight
9%
Receptor Agonist
8%
Genetic Loci
8%
Pathogenic Variants
8%
DNA Methylation Profiling
8%
1 Receptor
8%
Immune Checkpoint
8%
Herbal Medicinal
8%
Medicinal Plant Extracts
8%
Transgenic Models
8%
Qatari Adults
8%
FOXA2
8%
Retraction Notice
8%
Risk Factors
8%
Type 1 Diabetes Mellitus (T1DM)
8%
Loss Function
8%
Cas9 Protein
8%
Type I Diabetes
7%
Cell-based
7%
Transcriptome Analysis
7%
Lewy Body Disease
7%
Functional Studies
7%
Poor Prognosis
7%
Neurodevelopment
7%
Glucagon-like peptide-1 Receptor Agonists (GLP-1 RAs)
7%
Mesenchymal Stem Cells
7%
Age-associated
7%
Multiple System Atrophy
7%
Therapeutic Approaches
7%
Therapeutic Strategies
7%
Insulin Resistance
7%
Sequence Specificity
6%
Lipid Metabolism
6%
Related Disorders
6%
Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD)
6%
Adipocyte
6%
Colorectal Cancer Patients
6%
Consanguineous
6%
Highly Efficient
6%
Middle East and North Africa
6%
Therapeutic Targeting
6%
Vesicle Fusion
6%
Therapeutic Potential
6%
Major Depressive Disorder
6%
RNA Sequencing (RNA-seq)
6%
Body Mass Index
6%
Dysregulated
6%
Disease Progression
6%